JAKARTA – Following approval from independent shareholders on 21 August 2024, PT Sejahteraraya Anugrahjaya Tbk (SRAJ) is now preparing for a Capital Increase Without Pre-emptive Rights (PMTHMETD), or private placement.

According to a disclosure to the Indonesia Stock Exchange today (12/2), the managing company of Mayapada Hospital will issue 238,254,545 new shares at a nominal value of IDR 100 per share.

"All of these new shares will be subscribed by BCSS Maverick A (I), LP, which is not an affiliated party of the Company," the management said in an official statement.

With this PMTHMETD, the number of SRAJ shares will increase to 12.2 billion, with BCSS Maverick A (I) holding a 1.95% stake in SRAJ.

The private placement will be exercised at a price of IDR 2,200 per share, meaning that SRAJ is projected to raise fresh funds of up to IDR 524.16 billion from this corporate action.

The new shares are scheduled to be issued on February 20, 2025, followed by listing on the IDX on February 21, while the results of the private placement will be announced on February 24.

The management stated that the proceeds from the private placement will be allocated to settle the Company’s debt to its controlling shareholder, PT Surya Cipta Inti Cemerlang (SCIC).

As of January 2025, SCIC controls 59.99% of SRAJ shares, followed by High Pro Investments with 18.17%, WING HARVEST with 10.63%, and the public with 10.14%, while the remaining shares are held by individual affiliates of the company. (ZH)